1. Home
  2. Products
  3. Customized FluoroAb™
  4. CXCR4
  5. Anti-CXCR4 MAb (Clone 1)-iFluor® 555 Succinimidyl Ester

Anti-CXCR4 MAb (Clone 1)-iFluor® 555 Succinimidyl Ester (CAT#: WJY0-LS15802)

This product is comprised of an Humanized Anti-CXCR4 lgG4 Antibody (Clone 1) labeled with iFluor® 555 Succinimidyl Ester. iFluor® 555 Succinimidyl Ester is a Yellow-fluorescent dye and it's excitation/emission is 403/427 nm.

  • TARGET
  • ANTIBODY
  • DYE
  • Name
  • CXCR4
  • Alternative Names
  • NR2F1; BBOAS; BBSOAS; COUP-TFI; EAR-3; EAR3; ERBAL3; NR2F2; SVP44; TCFCOUP1; TFCOUP1; nuclear receptor subfamily 2 group F member 1; COUPTF1
  • Overview
  • Humanized Anti-CXCR4 lgG4 Antibody (Clone 1)
  • Species Reactivity
  • Human
  • Name
  • iFluor® 555 Succinimidyl Ester
  • Color
  • Yellow
  • Excitation⁄Emission (nm)
  • 557/570
  • Detection method
  • Fluorescent

For Research Use Only. NOT FOR CLINICAL USE.

Published Data

+ Submit Publications

Submit a review or a question

Scientific Resources

Customer Reviews and FAQs

There are currently no Customer reviews or questions for WJY0-LS15802. Click the button above to contact us or submit your feedback about this product.

Quick Links

Other Products

Same Target
CAT# Product Name Linker Payload
ADC-W-1925 Anti-CXCR4 (Ulocuplumab)-MC-Vc-PAB-MMAE ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) MMAE
ADC-W-1924 Anti-CXCR4 (Ulocuplumab)-MC-MMAF ADC MC (maleimidocaproyl) MMAF
ADC-W-519 Anti-CXCR4-PEG-S-4FB-dasatinib ADC PEG-S-4FB linker dasatinib
ADC-W-1926 Anti-CXCR4 (Ulocuplumab)-MC-Vc-PAB-SN38 ADC MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) SN-38 (7-ethyl-10-hydroxycamptothecin)
ADC-W-1927 Anti-CXCR4 (Ulocuplumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC MC-Vc-PAB-DMEA-(PEG2) duocarmycin SA

Online Inquiry

Name:
*Phone:
*E-mail Address:
*Products or Services Interested:
Company/Institution
Project Description:

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.